September 22, 2025
45 minutes
How to move the needle on GLP-1 ROI
Key takeaways
- Why muscle loss matters, and how movement protects long-term GLP-1 results
- How Sword Move drives behavior change and amplifies GLP-1 ROI
- Real-world examples of employers improving outcomes with movement and medication
GLP-1 medications like Wegovy® and Ozempic® are reshaping obesity and diabetes care, but without the right support, results may plateau and costs can surge.
In this webinar, Dr. Vijay Yanamadala, Sword Health’s chief medical officer, joins physical therapist Ellie Smith to explain how evidence-based movement can improve outcomes, preserve muscle, and increase the long-term value of your GLP-1 investment.
You’ll learn how Sword's Move helps members build lasting behavior change — and how employers are pairing it with GLP-1s to lower downstream spend, reduce MSK risk, and sustain weight loss.
Webinar Hosts
Chief Medical Officer at Sword Health
Senior Clinical Specialist
Hosts
Meet your hosts
Learn from Sword’s clinical experts as they share insights on GLP-1 strategy, behavior change, and long-term health outcomes.
Vijay Yanamadala
Chief Medical Officer at Sword Health
Ellie Smith
Senior Clinical Specialist
